Application | Comment | Organism |
---|---|---|
medicine | retreatment with PegIFN-alpha-2b and ribavirin for a minimum of 48 weeks should be considered in all patients with chronic hepatitis C unresponsive to previous IFN-based therapies. Baseline gamma-glutamyltransferase values and rapid virological response are highly predictive for retreatment outcome | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |